A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy & Safety

See also
Status	Clinical Trial	Phase
Completed	`NCT03007212` - Outcome of Transarterial Chemo-embolization (TACE) in Hepatocellular Carcinoma Patients With Partial Portal Vein Thrombosis	Phase 4
Terminated	`NCT03236649` - The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects	Phase 3
Withdrawn	`NCT04044326` - The Safety and Efficacy of Spherical Microwave Ablation for the Treatment of Malignant Liver Tumors	N/A
Recruiting	`NCT04687969` - Multimodal Machine Learning Characterization of Solid Tumors
Completed	`NCT02562755` - Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone	Phase 3
Withdrawn	`NCT02406508` - Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC	Phase 2
Completed	`NCT01972672` - The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma	Phase 2
Completed	`NCT01247298` - A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma	Phase 0
Completed	`NCT03735628` - An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors	Phase 1
Completed	`NCT02188901` - Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study	N/A
Active, not recruiting	`NCT04522908` - Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function	Phase 2
Terminated	`NCT01433016` - Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRI	Phase 2
Withdrawn	`NCT04465734` - A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC	Phase 3
Recruiting	`NCT05057013` - HMBD-001 in Advanced HER3 Positive Solid Tumours	Phase 1/Phase 2
Active, not recruiting	`NCT03753659` - IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)	Phase 2
Terminated	`NCT03144661` - An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies	Phase 1
Not yet recruiting	`NCT01821482` - A Study of DC-CIK to Treat Hepatocellular Carcinoma	Phase 2
Completed	`NCT03516071` - A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC	Phase 2
Completed	`NCT02794805` - Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis	Phase 2
Completed	`NCT02541149` - Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma	N/A

NCT number	NCT01761266
Study type	Interventional
Source	Eisai Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	March 1, 2013
Completion date	March 10, 2021

A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms